XML 89 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHAREHOLDERS' EQUITY (Narrative) (Details)
In Thousands, except Share data, unless otherwise specified
 0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended
Dec. 14, 2012
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2010
USD ($)
Dec. 31, 2012
ILS
Dec. 31, 2011
ILS
Dec. 31, 2012
Stock Options [Member]
USD ($)
Dec. 31, 2011
Stock Options [Member]
USD ($)
Dec. 31, 2010
Stock Options [Member]
USD ($)
Dec. 31, 2009
Stock Options [Member]
Dec. 31, 2008
Stock Options [Member]
Dec. 31, 2007
Stock Options [Member]
May 31, 2003
Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Minimum [Member]
Dec. 31, 2012
Stock Options [Member]
Maximum [Member]
Dec. 31, 2012
Warrants Issued to THCAP [Member]
Dec. 21, 2011
Long Term Convertible Note [Member]
USD ($)
Dec. 31, 2011
Long Term Convertible Note [Member]
USD ($)
Dec. 31, 2012
Long Term Convertible Note [Member]
USD ($)
Dec. 31, 2010
Long Term Convertible Note [Member]
USD ($)
Dec. 31, 2012
Scenario, Previously Reported [Member]
ILS
Oct. 05, 2010
Ordinary shares [Member]
USD ($)
Class of Stock [Line Items]                                            
Reverse stock split ratio 0.25                                          
Ordinary shares, par value per share         80.00 80.00                             20.00  
Ordinary shares, shares outstanding 1,118,081       1,132,685 1,116,981                             4,472,298  
Issuance of shares related to the private placement (net of $ 35 issuance expenses), shares                                           24,091
Ordinary shares issued, price per share                                           $ 12.44
Issuance of shares related to the private placement (net of $ 35 issuance expenses)       $ 265                                   $ 300
Debt Instrument [Line Items]                                            
Amount of debt converted                                 2,523          
Debt conversion, price per share                                 $ 6     $ 13    
Shares issued in conversion                                 420,491          
Number shares covered by warrants                               3,600 160,996          
Warrant extension term                                 2 years          
Term of warrants                               3 years            
Exercise price of warrants                               2.39            
Compensation caused directly from extension                                   86        
Debt instrument, principal amount                                     501      
Stated interest rate                                     4.00%      
Balance of the deferred loan                                     527      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Ordinary shares reserved for purchase             275,000   208,000 130,000 75,000 50,000 31,250                  
Options still available for future grants             144,982                              
Option term                           3 years 10 years              
Vesting period             4 years                              
Options exercised, price                                             
Weighted-average grant-date fair value of options granted               $ 6.76                            
Total intrinsic value of options exercised             5 33 62                          
Financial expenses   $ 781 $ 2,241 $ 961     $ 21